Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States.
Diphtheria
/ prevention & control
Diphtheria-Tetanus-Pertussis Vaccine
/ administration & dosage
Female
Haemophilus Vaccines
/ administration & dosage
Hepatitis B
/ prevention & control
Hepatitis B Vaccines
/ administration & dosage
Humans
Immunization Schedule
Immunization, Secondary
Immunogenicity, Vaccine
Infant
Male
Poliomyelitis
/ prevention & control
Poliovirus Vaccine, Inactivated
/ administration & dosage
Tetanus
/ prevention & control
United States
Vaccines, Combined
/ administration & dosage
Whooping Cough
/ prevention & control
type b
acellular pertussis
diphtheria
hepatitis B
immunogenicity
infants
non-inferiority
poliovirus
safety
tetanus
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
2019
2019
Historique:
pubmed:
18
11
2018
medline:
29
2
2020
entrez:
17
11
2018
Statut:
ppublish
Résumé
Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis and Haemophilus influenzae type b vaccine (DTaP-HBV-IPV/Hib) can further reduce the number of injections in pediatric immunization schedules of countries currently using pentavalent DTaP combination vaccines. This open-label, randomized, multicenter study (NCT02096263) conducted in the United States evaluated the immunogenicity and safety of DTaP-HBV-IPV/Hib vaccine compared with concomitant administration of DTaP-HBV-IPV and Hib
Identifiants
pubmed: 30444673
doi: 10.1080/21645515.2018.1549449
pmc: PMC6605854
doi:
Substances chimiques
Diphtheria-Tetanus-Pertussis Vaccine
0
Haemophilus Vaccines
0
Hepatitis B Vaccines
0
Poliovirus Vaccine, Inactivated
0
Vaccines, Combined
0
diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine
0
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
809-821Références
Vaccine. 2010 Jun 7;28(25):4192-203
pubmed: 20417262
Bull World Health Organ. 1988;66(4):443-55
pubmed: 2971466
MMWR Morb Mortal Wkly Rep. 2003 Mar 14;52(10):203-4
pubmed: 12653460
Lancet. 1996 Dec 21-28;348(9043):1688-92
pubmed: 8973430
Pediatr Infect Dis J. 1997 Sep;16(9):863-70
pubmed: 9306481
Expert Rev Vaccines. 2018 Jun;17(6):513-524
pubmed: 29920121
Clin Drug Investig. 2005;25(5):315-23
pubmed: 17532669
Vaccine. 2006 Apr 24;24(17):3505-12
pubmed: 16524648
Eur J Pediatr. 1997 Jan;156(1):18-24
pubmed: 9007484
Lancet Infect Dis. 2018 Jul;18(7):749-757
pubmed: 29752131
Expert Rev Vaccines. 2017 Nov;16(11):1095-1105
pubmed: 28971707
Scand J Infect Dis. 2004;36(8):585-92
pubmed: 15370670
Vaccine. 2001 Mar 21;19(17-19):2280-5
pubmed: 11257348
Clin Infect Dis. 1999 May;28(5):995-1001
pubmed: 10452624
J Glob Infect Dis. 2011 Jan;3(1):63-72
pubmed: 21572611
J Biol Stand. 1983 Apr;11(2):137-44
pubmed: 6345548
Lancet. 1999 Dec 11;354(9195):2063-8
pubmed: 10636384
Vaccine. 2004 Jun 2;22(17-18):2226-33
pubmed: 15149781
N Engl J Med. 2012 Sep 13;367(11):1012-9
pubmed: 22970945
Hum Vaccin Immunother. 2015;11(9):2132-41
pubmed: 26075806
J Infect Dis. 1984 Jun;149(6):1034-5
pubmed: 6610714
Pediatr Infect Dis J. 2005 May;24(5 Suppl):S58-61
pubmed: 15876927
MMWR Morb Mortal Wkly Rep. 2009 Sep 18;58(36):1008-9
pubmed: 19763078
J Infect Dis. 1983 Jun;147(6):1100
pubmed: 6602191
J Clin Microbiol. 1984 Oct;20(4):772-4
pubmed: 6386879
MMWR Recomm Rep. 1991 Nov 22;40(RR-13):1-25
pubmed: 1835756
MMWR Morb Mortal Wkly Rep. 2016 Apr 29;65(16):418-9
pubmed: 27124887
J Infect Dis. 2005 Jan 1;191(1):58-64
pubmed: 15593004
J Pediatr. 2000 Sep;137(3):304-12
pubmed: 10969252